HY
Hyloris
HYL.BR·EBRLiege BEFounded 201230 employees
Micro CappharmaPublicOncology
Platform: IV Reformulation
Market Cap
$0.1B
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (HYL.BR)
Loading HYL.BR stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elrabrutinib | HYL-4876 | Phase 3 | 4 | BCMA | Endometrial Ca | ||
| Lisotuximab | HYL-1423 | Phase 2/3 | 2 | FcRn | ALLPTSD |
SEC Filings & Financial Documents
SEC filings are not available for EBR-listed companies.
Hyloris trades on EBR (BE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)